Hyo-Soo Kim

About Hyo-Soo Kim

Hyo-Soo Kim, With an exceptional h-index of 107 and a recent h-index of 62 (since 2020), a distinguished researcher at Seoul National University, specializes in the field of stem cell, intervention, stent, molecular biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Transradial Versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stent

Impact of Age on Antiplatelet Monotherapy in the Chronic Maintenance Period After Percutaneous Coronary Intervention: A Post Hoc Analysis From the HOST-EXAM Extended Study

Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice

Resistin impairs mitochondrial homeostasis via cyclase-associated protein 1-mediated fission, leading to obesity-induced metabolic diseases

Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry

TCT-255 Sex Differences in Procedural Characteristics and Clinical Outcomes Among Patients Undergoing Bifurcation PCI Using Second-Generation Drug-Eluting Stents

Recombinant vector comprising ERT2 fused to CAS9

Hyo-Soo Kim Information

University

Position

Seoul National University Hospital

Citations(all)

51786

Citations(since 2020)

20239

Cited By

42382

hIndex(all)

107

hIndex(since 2020)

62

i10Index(all)

485

i10Index(since 2020)

317

Email

University Profile Page

Google Scholar

Hyo-Soo Kim Skills & Research Interests

stem cell

intervention

stent

molecular biology

Top articles of Hyo-Soo Kim

Transradial Versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stent

Journal of Korean Medical Science

2024/3/3

Impact of Age on Antiplatelet Monotherapy in the Chronic Maintenance Period After Percutaneous Coronary Intervention: A Post Hoc Analysis From the HOST-EXAM Extended Study

Canadian Journal of Cardiology

2024/1/1

Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

BMC cardiovascular disorders

2023/1/9

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice

2016/10/15

Resistin impairs mitochondrial homeostasis via cyclase-associated protein 1-mediated fission, leading to obesity-induced metabolic diseases

Metabolism

2023/1/1

Ju-Young Kim
Ju-Young Kim

H-Index: 3

Hyo-Soo Kim
Hyo-Soo Kim

H-Index: 67

Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry

Cardiology journal

2023

TCT-255 Sex Differences in Procedural Characteristics and Clinical Outcomes Among Patients Undergoing Bifurcation PCI Using Second-Generation Drug-Eluting Stents

Journal of the American College of Cardiology

2023/10/24

Recombinant vector comprising ERT2 fused to CAS9

2023/10/17

Impact of diabetes on long‐term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry

Catheterization and Cardiovascular Interventions

2023/10

Lipoprotein (a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome

Canadian Journal of Cardiology

2023/10/1

Comparison of standard ticagrelor and prasugrel therapies based on previous trials

European heart journal

2023/8/21

Jeehoon Kang
Jeehoon Kang

H-Index: 8

Hyo-Soo Kim
Hyo-Soo Kim

H-Index: 67

Clopidogrel vs Aspirin in the Chronic Maintenance Period for Patients With Acute Coronary Syndrome

European Heart Journal

2023/11

Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial

JAMA cardiology

2023/6/1

Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation

2023/5/25

Comparison of 3-to 6-month versus 12-month dual antiplatelet therapy after coronary intervention using the contemporary drug-eluting stents with ultrathin struts: the HOST-IDEA …

Circulation

2023/5/2

Association of clinical outcomes with sex in patients receiving chronic maintenance antiplatelet monotherapy after percutaneous coronary intervention: a post hoc gender …

Journal of the American Heart Association

2023/4/18

Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis

European heart journal

2023/4/14

Cost-effectiveness of clopidogrel vs aspirin monotherapy after percutaneous coronary intervention: results from the HOST-EXAM study

JACC: Asia

2023/4/1

Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

European Heart Journal-Cardiovascular Pharmacotherapy

2023/4

Identification of cell-biologic mechanisms of coronary artery spasm and its ex vivo diagnosis using peripheral blood-derived iPSCs

Biomaterials Research

2023/2/18

See List of Professors in Hyo-Soo Kim University(Seoul National University)